Travel time may impact breast cancer treatment completion
NCT ID NCT07527741
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 4 times
Summary
This study looks at how the location of treatment affects whether people with early-stage HER2-positive breast cancer stick to their therapy plan. Researchers will compare patients who have to travel far for treatment with those who don't. The goal is to see if making treatment more local helps people complete their full course of care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY STAGE HER2+ BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
General Hospital "Dr Laza K. Lazarevic" Sabac
RECRUITINGŠabac, Popa Karana 2-4, 15000, Serbia
-
General Hospital ''Stefan Visoki'' Smederevska Palanka
RECRUITINGSmederevska Palanka, Vuka Karadžića 147, 11420, Serbia
-
General Hospital Pančevo
RECRUITINGPančevo, Miloša Trebinjca 11, 26000, Serbia
-
General Hospital Požarevac
RECRUITINGPožarevac, Bratstva Jedinstva 135, 12000, Serbia
-
Health Centre ''Sveti Luka'' Smederevo
RECRUITINGSmederevo, Knez Mihailova 51, 11300, Serbia
-
Health Centre Kladovo
RECRUITINGKladovo, Dunavska 1-3, 19320, Serbia
-
Health Centre Loznica
RECRUITINGLoznica, Bolnička 65, 15300, Serbia
-
Health Centre Valjevo
RECRUITINGValjevo, Sinđelićeva 62, 14000, Serbia
-
Healthcare Centre Bor
RECRUITINGBor, Dragiše Mišovića 1, 19210, Serbia
-
Institute for Onocology and Radiology of Serbia
RECRUITINGBelgrade, Pasterova 14, 11000, Serbia
More trials for these conditions
Other studies related to the condition(s) this trial covers.